Open Beta
MetriLume

US marketsCRVO

SEC-sourced researchBeta

CRVO

CervoMed Inc.

Company comparison ↗

Data passport

CIK
0001053691
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 28, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 9,737,974.0000 USD; December 2025: 4,006,510.0000 USD9.7M USD0 USD0December 2024December 2025
CRVO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20249,737,974.0000Mar 13, 2026
December 20254,006,510.0000Mar 13, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20254,006,510.0000-26,966,367.0000-23,449,963.000022,879,018.00004,656,117.0000Mar 13, 2026
December 20249,737,974.0000-16,290,695.0000-16,530,827.000043,081,610.00003,879,282.0000Mar 13, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$4.01MDecember 2025Mar 13, 202610-K
Previous period revenueRevenues$9.74MDecember 2024Mar 13, 202610-K
Net incomeNetIncomeLoss-$26.97MDecember 2025Mar 13, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$23.45MDecember 2025Mar 13, 202610-K
Total assetsAssets$22.88MDecember 2025Mar 13, 202610-K
Total liabilitiesLiabilities$4.66MDecember 2025Mar 13, 202610-K

New filings

Explore methodology ↗